This page uses CSS to present the content in the best possible manner. If you can see this message, then CSS (or JavaScript) is not enabled in your browser, and the page will not appear as intended.

References

  1. Ahluwalia A & Perretti M; (1999); B1 receptors as a new inflammatory target. Could this B the 1?; Trends in Pharmacological Sciences; 20, 100-4
  2. Akerman S, Williamson DJ, Kaube H & Goadsby PJ; (2002); Nitric oxide synthase inhibitors can antagonize neurogenic and Calcitonin gene-related peptide induced dilation of dural meningal vessels; British Journal of Pharmacology; 137(1), 62-8
  3. Akerman S, Williamson DJ, Kaube H & Goadsby PJ; (2002); The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels; European Journal of Pharmacology; 452, 223-228
  4. Axon Instruments, Inc; (1999); CD: Axon Guide to Perforated Patch Clamp
  5. Brown AG; (1991); Nerve Cells and Nervous Systems; Pub. Springer-Verlag, London
  6. Buzzi MG; (2001); Trigeminal pain pathway: peripheral and central activation as experimental models of migraine; Functional Neurology;16(4 Suppl), 77-81
  7. Cesare P & McNaughton P; (1997); Peripheral pain mechanisms; Current Opinion in Neurobiology; 7, 493-499
  8. Davidoff RA; (1995); Migraine: Manifestations, Pathogenesis and Management; Pub. FA Davis Company, Philadelphia
  9. de Tommaso M, Murasecco D, Libro G, Guido M, Sciruicchio V, Specchio LM, Gallai V & Puca F; (2002); Modulation of trigeminal reflex excitability in migraine: effects of attention and habituation on the blink reflex; International Journal of Psychophysiology; 44(3), 239-49
  10. Devoto M, Lozito A, Staffa G, D’Allessandro R, Sacquengna T & Romeo G; (1986); Segregation analysis of migraine in 128 families; Cephalalgia; 6, 101-105
  11. Dostrovsky JO, Davis KD & Kawakita K; (1991); Central mechanisms of vascular headaches; Canadian Journal of Physiology & Pharmacology; 69, 652-658
  12. Durham PL & Russo AF; (1999); Regulation of Calcitonin Gene-Related Peptide Secretion by a Serotonergic Antimigraine Drug ; The Journal of Neuroscience; 19(9), 3423-3429
  13. Durham PL & Russo AF; (2002); New insights into the molecular actions of serotonergic antimigraine drugs; Pharmacology & Therapeutics; 94, 77-92
  14. Durham PL & Russo AF; (2003); Stimulation of the Calcitonin Gene-Related Peptide Enhancer by Mitogen-Activated Protein Kinases and Repression by an Antimigraine Drug in Trigeminal Ganglia Neurons; The Journal of Neuroscience; 23(3), 807-815
  15. Durham PL, Sharma RV & Russo AF; (1997); Repression of the Calcitonin Gene-Related Peptide Promoter by 5-HT1 Receptor Activation; The Journal of Neuroscience; 17(24), 9545–9553
  16. Ebersberger A; (2002); Pathophysiology of migraine: models to explain the generation of migraine headache; Anaesthesist; 51(8), 661-7
  17. Ferreira J, Campos MM, Arau´jo R, Bader M, Pesquero JB & Calixto JB; (2002); The use of kinin B1 and B2 receptor knockout mice and selective antagonists to characterize the nociceptive responses caused by kinins at the spinal level; Neuropharmacology; 43, 1188-1197
  18. Fitzgerald MJT & Folan-Curran J; (2002); Clinical Neuroanatomy and related Neuroscience; Pub. WB Saunders
  19. Giffin NJ & Kaube H; The electrophysiology of migraine; Current Opinion in Neurology;15(3), 303-9
  20. Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L & Connor HE; (2002); Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission; Brain; 125(Pt 6), 1392-401
  21. Hans M, Luvisetto S, Williams ME, Spagnolo M, Urrutia A, Tottene A, Brust PF, Johnson EC, Harpold MM, Stauderman KA &, Pietrobon D; (1999); Functional Consequences of Mutations in the Human a1A Calcium Channel Subunit Linked to Familial Hemiplegic Migraine; The Journal of Neuroscience; 19(5), 1610–1619
  22. Hou M, Kanje M, Longmore J, Tajti J, Uddman R & Edvinsson L; (2001); 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase; Brain Research; 909(1-2), 112-20
  23. http://migraine.org.uk
  24. Katsarava Z, Lehnerdt G, Duda B, Ellrich J, Diener HC & Kaube H; (2002); Sensitization of trigeminal nociception specific for migraine but not pain of sinusitis; Neurology; 59(9), 1450-3.
  25. Kaube H, Katsarava Z, Przywara S, Drepper J, Ellrich J & Diener HC; Acute migraine headache: possible sensitisation of neurons in the spinal trigeminal nucleus?; Neurology; 58(8), 1234-8
  26. Knight YE, Bartsch T, Kaube H & Goadsby PJ; (2002); P/Q-Type Calcium-Channel Blockade in the Periaqueductal Gray Facilitates Trigeminal Nociception: A Functional Genetic Link for Migraine?; The Journal of Neuroscience; 22, RC213 (1–6).
  27. Knyihar-Csillik E, Tajti J, Chadaide Z, Csillik B & Vecsei L; (2001); Functional immunohistochemistry of neuropeptides and nitric oxide synthase in the nerve fibres of the supratentorial dura mater in an experimental migraine model; Microscopy Research and Technique; 53(3), 193-211
  28. Levy D & Strassman AM; Mechanical response properties of A and C primary afferent neurons innervating the rat intracranial dura; Journal of Neurophysiology; 88(6), 3021-31
  29. Longstaff A; (2000); Neuroscience Instant Notes; Pub. BIOS Scientific Publishers Ltd., Oxford
  30. Marieb E; (1999); Human Anatomy & Physiology; Pub. Benjamin Cummings Science Publishing, California
  31. McCall RB, Huff R, Chio CL, TenBrink R, Bergh CL, Ennis MD, Ghazal NB, Hoffman RL, Meisheri K, Higdon NR & Hall E; (2002); Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633; Cephalalgia; 22(10), 799-806
  32. Millan MJ; (1999); The Induction of Pain: An Integrative Review; Progress in Neurobiology; 57, 1-164
  33. Mitsikostas DD & Sanchez del Rio M; Receptor systems mediating c-fos expression within trigeminal nucleus caudalis in animal models of migraine; Brain Research. Brain Research Reviews; 35(1), 20-35
  34. Miyamoto A, Laufs U, Pardo C & Liao JK; (1997); Modulation of Bradykinin Receptor Ligand Binding Affinity and Its Coupled G-proteins by Nitric Oxide; Journal of Biological Chemistry; 272; 31, 19601-19608
  35. Moskowitz MA, Buzzi MG, Sakas DE & Linnik MD; (1989); Pain mechanisms underlying vascular headaches; Revista de Neurologia; 145, 181-193
  36. Moskowitz MA; (1991); The visceral organ brain: Implications for the pathophysiology of vascular headache; Neurology; 41, 182-186
  37. O'Connor TP & van der Kooy D; (1986); Pattern of intracranial and extracranial projections of trigeminal ganglion cells; Journal of Neuroscience; 6, 2200-2207
  38. O'Connor TP & van der Kooy D; (1988); Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries; Journal of Neuroscience; 8, 2468-2476
  39. Parsons AA, Strijbos PJ; (2003); The neuronal versus vascular hypothesis of migraine and cortical spreading depression; Current Opinion in Pharmacology; 3(1), 73-7
  40. Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia AS, McNamara JO & Williams SM; (2001); Neuroscience; Pub. Sinauer Associates
  41. Rang HP, Dale MM & Ritter JM; (1999); Pharmacology; Pub. Churchill Livingstone, London
  42. Russel MB & Oleson J; (1993); The genetics of migraine without aura and migraine with aura; Cephalalgia; 13, 245-248
  43. Sanchez del Rio M, Reuter U & Moskowitz MA; (2000); Central and peripheral mechanisms of migraine; Functional Neurology; 15 Suppl 3, 157-62
  44. Sandler M, Ferrari M & Harnett S; (1996); Migraine Pharmacology and Genetics; Pub. Altman, London
  45. Sandrini G, Cecchini PA, Milanov I, Tassorelli C, Buzzi MG & Nappi G; (2002); Electrophysiological evidence for trigeminal neuron sensitization in patients with migraine; Neuroscience Letters; 317, 135-138
  46. Seigel GJ, Agranoff BW, Albers RW, Fisher SK & Uhler MD; (1999); Basic Neurochemistry; Pub. Lippencott Williams & Williams, London
  47. Sherwood L; (1997); Human Physiology; Pub. Wadsworth Publishing Company, London
  48. Smith D, Hill RG, Edvinsson L & Longmore J; (2002); An immunocytochemical investigation of human trigeminal nucleus caudalis: CGRP, substance P and 5-HT1D-receptor immunoreactivities are expressed by trigeminal sensory fibres; Cephalalgia; 22(6), 424-31
  49. Smith PA; (2002); Lecture: Role of primary afferent fibres in somatosensory processing; Neurobiology of Pain Notes, University of Nottingham
  50. Smith PA; (2003); Experimental Research Data & Poster Presentations; University of Nottingham
  51. Solomon GD, Lee TG & Solomon CS; (1998); Clinician’s Manual on Migraine; Pub. Science Press, London
  52. Srikiatkhachorn A, Suwattanasophon C, Ruangpattanatawee U & Phansuwan-Pujito P; (2002); 2002 Wolff Award: 5 -HT2A receptor activation and nitric oxide synthesis: a possible mechanism determining migraine attacks; Headache; 42(7), 566-74
  53. Stanford IM & Cooper AJ; (2000); Electrophysiological and morphological characterisation of rat globus pallidus neurones in vitro; The Journal of Physiology; 525P, 52
  54. Tfelt-Hansen P, De Vries P & Saxena PR; (2000); Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy; Drugs; 60(6), 1259-87
  55. Toole G & Toole S; (1997); Advanced Human and Social Biology; Pub. Stanley Thornes, Cheltenham
  56. Tortora G, Anagnostakos N; (1990); Principles of Anatomy & Physiology; Pub. Harper Collins, New York
  57. Uddman R, Tajti J, Hou M, Sundler F & Edvinsson L; (2002); Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2; Cephalalgia; 22(2), 112-6
  58. Williamson DJ & Hargreaves RJ; (2001); Neurogenic inflammation in the context of migraine.; Microscopy Research and Technique; 53(3), 167-78
Migraine and Bradykinin (logo)
vertical element of logo